Medtech
This function is exclusive for Premium subscribers
-
DATABASE (98)
-
ARTICLES (64)
The Hague-based social impact investor invests in the areas of environment, economic inclusion, health and well-being and follows the socio-economic principles of the United Nation’s Global Social Development Goals. The VC was established in 2019 and to date has invested in four companies. Its most recent investments have been in agritech sustainability monitoring platform Satelligence’s $2.3m seed round and AI-powered sustainable recruiting platform Equalture’s €1m seed round.
The Hague-based social impact investor invests in the areas of environment, economic inclusion, health and well-being and follows the socio-economic principles of the United Nation’s Global Social Development Goals. The VC was established in 2019 and to date has invested in four companies. Its most recent investments have been in agritech sustainability monitoring platform Satelligence’s $2.3m seed round and AI-powered sustainable recruiting platform Equalture’s €1m seed round.
Kaszek Ventures is an Argentinian VC co-founded in 2011 by Hernan Kazah and Nicolas Szekasy, both hailing from Latin America’s e-commerce success story MercadoLibre. Starting with $95m, the VC made its first investment in Brazilian fintech, Nubank. The VC now has over 159 investments and has managed 21 exits. It mainly focuses on B2C solutions, mobile, healthcare technology, retail and media.The most recent Kaszek investment is in Latin America’s leading crypto platform Bitso, co-leading Bitso’s $62m Series B round with QED Investors. Managing partner Szekasy has also joined Bitso’s board. Existing shareholders Coinbase Ventures and Pantera Capital joined the Bitso round.In 2019, Kaszek raised two new funds securing a total of $600m to invest in later-growth stage companies to tap into Latin America’s rapidly maturing tech ecosystems. The rollout of 4G has also helped to speed up the adoption of new technologies across the region, according to Kazah.
Kaszek Ventures is an Argentinian VC co-founded in 2011 by Hernan Kazah and Nicolas Szekasy, both hailing from Latin America’s e-commerce success story MercadoLibre. Starting with $95m, the VC made its first investment in Brazilian fintech, Nubank. The VC now has over 159 investments and has managed 21 exits. It mainly focuses on B2C solutions, mobile, healthcare technology, retail and media.The most recent Kaszek investment is in Latin America’s leading crypto platform Bitso, co-leading Bitso’s $62m Series B round with QED Investors. Managing partner Szekasy has also joined Bitso’s board. Existing shareholders Coinbase Ventures and Pantera Capital joined the Bitso round.In 2019, Kaszek raised two new funds securing a total of $600m to invest in later-growth stage companies to tap into Latin America’s rapidly maturing tech ecosystems. The rollout of 4G has also helped to speed up the adoption of new technologies across the region, according to Kazah.
SoftBank announced its second Vision Fund of about $108bn in July 2019 to invest in technology startups across the world. SoftBank had originally planned to contribute $38bn to the new fund. However, its Vision Fund I was badly affected by the Covid-19 pandemic and losses resulting in lower valuations of its investments in Uber and WeWork.In February 2020, the Japanese conglomerate decided to inject more money into the Vision Fund II before raising new funds from other LPs. With $10bn committed to the second fund by the SoftBank Group, the new fund has now invested in 13 portfolio companies including co-leading the Series C round for XAG in November 2020.
SoftBank announced its second Vision Fund of about $108bn in July 2019 to invest in technology startups across the world. SoftBank had originally planned to contribute $38bn to the new fund. However, its Vision Fund I was badly affected by the Covid-19 pandemic and losses resulting in lower valuations of its investments in Uber and WeWork.In February 2020, the Japanese conglomerate decided to inject more money into the Vision Fund II before raising new funds from other LPs. With $10bn committed to the second fund by the SoftBank Group, the new fund has now invested in 13 portfolio companies including co-leading the Series C round for XAG in November 2020.
Founded in 2011, Ankur Capital is an early-stage venture capital fund based in Mumbai. The VC invests in Indian-based startups in diverse sectors like agritech, food, health and education. It has 15 startups in its investment portfolio and has managed one exit to date, Carmel Organics.Recent investments include seed funding for seafood supply chain platform Captain Fresh and agriproduce marketplace Vegrow, as well as participation in the $20m Series C round of predictive farming platform Cropin.
Founded in 2011, Ankur Capital is an early-stage venture capital fund based in Mumbai. The VC invests in Indian-based startups in diverse sectors like agritech, food, health and education. It has 15 startups in its investment portfolio and has managed one exit to date, Carmel Organics.Recent investments include seed funding for seafood supply chain platform Captain Fresh and agriproduce marketplace Vegrow, as well as participation in the $20m Series C round of predictive farming platform Cropin.
Founded in 1997, Seventure Partners is one of Europe’s most prolific VC investors with a portfolio of over 200 startups across both tech and non-tech sectors. The French VC has also managed more than 40 exits in total. It mainly focuses on fintech and insurtech, French and German startups and in life sciences in Europe, North America and Asia.Its five funds cover different market segments, ranging from €24m–€200m, with investments of €500,000–€10m per round. Total funding for a company can reach €20m, right through the early to late stages. Recent investments include the $6.7m Series A round of US biotech Dermala and the $10.7m Series A round of US self-cleaning water bottle startup LARQ.
Founded in 1997, Seventure Partners is one of Europe’s most prolific VC investors with a portfolio of over 200 startups across both tech and non-tech sectors. The French VC has also managed more than 40 exits in total. It mainly focuses on fintech and insurtech, French and German startups and in life sciences in Europe, North America and Asia.Its five funds cover different market segments, ranging from €24m–€200m, with investments of €500,000–€10m per round. Total funding for a company can reach €20m, right through the early to late stages. Recent investments include the $6.7m Series A round of US biotech Dermala and the $10.7m Series A round of US self-cleaning water bottle startup LARQ.
Founded in 2016, Shanjin Capital is a PE fund manager approved by the Asset Management Association of China. With a focus on new energy and emerging technologies, the firm mainly invests in clean energy, connected vehicles, medtech and healthcare.
Founded in 2016, Shanjin Capital is a PE fund manager approved by the Asset Management Association of China. With a focus on new energy and emerging technologies, the firm mainly invests in clean energy, connected vehicles, medtech and healthcare.
Founded in 2019 in Silicon Valley, Concrete Rose is focused on diversity by investing in under-represented founders and companies serving under-represented consumers at the early-stage and across market segments. It currently has 14 companies in its portfolio and its most recent investments in January 2021 include the $3.5m seed round of inclusive car insurer Loop and in the $17.1m seed round of HR analytics software Syndio
Founded in 2019 in Silicon Valley, Concrete Rose is focused on diversity by investing in under-represented founders and companies serving under-represented consumers at the early-stage and across market segments. It currently has 14 companies in its portfolio and its most recent investments in January 2021 include the $3.5m seed round of inclusive car insurer Loop and in the $17.1m seed round of HR analytics software Syndio
Founded in 1999, TLCOM Capital now has offices in Kenya, Nigeria and the UK. Originally a global VC investor, its key investment objective now is to tackle Africa’s greatest challenges via its TIDE Africa Fund that was established in 2017.Total funding to date stands at $300m and investments range from $500,000 to $10m. It currently has 12 portfolio companies and has managed 13 exits. Recent investments include the $6m Series A round of Kenyan agro-focused insurtech PULA and the $7.5m Series A round of Nigerian edtech uLesson Education.
Founded in 1999, TLCOM Capital now has offices in Kenya, Nigeria and the UK. Originally a global VC investor, its key investment objective now is to tackle Africa’s greatest challenges via its TIDE Africa Fund that was established in 2017.Total funding to date stands at $300m and investments range from $500,000 to $10m. It currently has 12 portfolio companies and has managed 13 exits. Recent investments include the $6m Series A round of Kenyan agro-focused insurtech PULA and the $7.5m Series A round of Nigerian edtech uLesson Education.
Vesalius Biocapital III is a €70 million fund that invests in medtech, e-health initiatives and drug development in Europe. It was launched in 2017 by Luxembourg-based Vesalius Biocapital, a life sciences venture capital firm founded in 2007. Preceding Vesalius Biocapital III were Vesalius Biocapital I, with €76 million under management and Vesalius Biocapital II, which has €78 million invested; both funds have 11 portfolio companies each.Its recent investments include in Portuguese home physiotherapy tech solution SWORD Health's 2021 $25m Series B and in the 2020 $9m second phase of its Series A round as well as in the 2020 €22m Series B round of German biotech Topas Therapeutics.
Vesalius Biocapital III is a €70 million fund that invests in medtech, e-health initiatives and drug development in Europe. It was launched in 2017 by Luxembourg-based Vesalius Biocapital, a life sciences venture capital firm founded in 2007. Preceding Vesalius Biocapital III were Vesalius Biocapital I, with €76 million under management and Vesalius Biocapital II, which has €78 million invested; both funds have 11 portfolio companies each.Its recent investments include in Portuguese home physiotherapy tech solution SWORD Health's 2021 $25m Series B and in the 2020 $9m second phase of its Series A round as well as in the 2020 €22m Series B round of German biotech Topas Therapeutics.
Founded in 2015, M25 is an early-stage VC based in Chicago, investing solely in companies headquartered in the US Midwest across tech sectors, almost exclusively at seed stage. It currently has 77 companies in its portfolio and has managed eight exits to date. Its most recent investments include in gaming monetization app Metafy’s $3m seed round in December 2020 and in the $2.7m seed round of mobile online store creation app CASHDROP in August 2020. It invests from $100,000 at the idea stage through to $25m per startup.Im sorry but I dont see that investing in 15 different sectors is actually a focus that is why I put General. it´s mosre like what sectors do they not invest in?
Founded in 2015, M25 is an early-stage VC based in Chicago, investing solely in companies headquartered in the US Midwest across tech sectors, almost exclusively at seed stage. It currently has 77 companies in its portfolio and has managed eight exits to date. Its most recent investments include in gaming monetization app Metafy’s $3m seed round in December 2020 and in the $2.7m seed round of mobile online store creation app CASHDROP in August 2020. It invests from $100,000 at the idea stage through to $25m per startup.Im sorry but I dont see that investing in 15 different sectors is actually a focus that is why I put General. it´s mosre like what sectors do they not invest in?
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
Founded in Connecticut in 2014, Oak has a total of $3.3bn assets under management, the overwhelming majority within healthcare and fintech, and invests at all stages of growth. Approximately one third of its portfolio companies that currently number 55, seek re-investment from the VC. It has managed eight exits to date and has a special interest in investing in women in tech.Its most recent investments have included in Canadian unicorn the startup financing fintech Clearco that raised $100m in its April 2021 Series C round, and, the same month, in US virtual healthcare platform Firefly Health’s $40m Series B round.
Founded in Connecticut in 2014, Oak has a total of $3.3bn assets under management, the overwhelming majority within healthcare and fintech, and invests at all stages of growth. Approximately one third of its portfolio companies that currently number 55, seek re-investment from the VC. It has managed eight exits to date and has a special interest in investing in women in tech.Its most recent investments have included in Canadian unicorn the startup financing fintech Clearco that raised $100m in its April 2021 Series C round, and, the same month, in US virtual healthcare platform Firefly Health’s $40m Series B round.
M Capital Partners is a leading private equity firm in the French small-cap market. It specializes in SME financing in the development and transmission phases. Based in Paris, the company has offices in Toulouse, Nice, Montepellier and Bordeaux. Founded 17 years ago, M Capital has €530m under active management. It is engaged in venture and capital investments, real estate, and impact investing. Recently it declared its aim to obtain the B Corp sustainability label, and created a foundation and several positive impact funds and moved to decarbonize its portfolio.
M Capital Partners is a leading private equity firm in the French small-cap market. It specializes in SME financing in the development and transmission phases. Based in Paris, the company has offices in Toulouse, Nice, Montepellier and Bordeaux. Founded 17 years ago, M Capital has €530m under active management. It is engaged in venture and capital investments, real estate, and impact investing. Recently it declared its aim to obtain the B Corp sustainability label, and created a foundation and several positive impact funds and moved to decarbonize its portfolio.
Aquiti Gestion is a 20-year old capital investment company focused on supporting startups in the seed and Series A stage in the Nouvelle-Aquitaine region of France’s southwest. It counts more than 200 companies in its portfolio and some €200m under management. It has three offices and 18 staff.
Aquiti Gestion is a 20-year old capital investment company focused on supporting startups in the seed and Series A stage in the Nouvelle-Aquitaine region of France’s southwest. It counts more than 200 companies in its portfolio and some €200m under management. It has three offices and 18 staff.
IRDI Capital Investissement supports innovative startups and local SMEs in southwest France, with offices in Bordeaux, Toulouse, and Montpellier. Over its 40-year history, the company has invested some €800m in more than 1,400 companies.
IRDI Capital Investissement supports innovative startups and local SMEs in southwest France, with offices in Bordeaux, Toulouse, and Montpellier. Over its 40-year history, the company has invested some €800m in more than 1,400 companies.
SWITCH Singapore 2021: How to harness the power of the deep tech ecosystem
Investor Jason Illian of Koch Disruptive Technologies talks talent, scaling for deep tech startups, and why longer gestation periods and mid-course pivots don’t have to be deal breakers
SWITCH Singapore 2021: Benefits and challenges of AI applications in healthcare
Medical experts and healthcare startups agree AI can contribute more to healthcare beyond improving diagnosis and personalized treatment, but hurdles still remain
Sequoia China Seed Fund: Growing an era of deep-tech startups
Managing Partner Neil Shen wants to help deep-tech and enterprise tech startups get investments more easily, across quantum computing, semiconductors, synthetic biology and more
South Summit 2021: Martin Varavsky, Leandro Sigman on post-Covid healthcare trends
Serial entrepreneur Martin Varavsky and Insud Pharma Chairman Leandro Sigman share their thoughts and projections on the future of health tech
Intudo Ventures: Grooming returning overseas talent for an Indonesia-only bet
Combining the experience and networks of foreign-educated Indonesians with local distribution channels, Intudo’s hyperlocal strategy has attracted $200m in managed assets
ARTICARES: Personalized, more affordable arm rehab therapy at home
Using adaptive AI, its H-Man robot works like an occupational therapist, assessing patient’s performance and adjusting the complexity of training tasks in real time
Sequoia Capital China holds steady with investments in healthcare, biotech and green economy
China’s most active investor increases bets on sectors beyond the consumer internet and edtech recently hurt by regulatory clampdown
New sectors, strategies come into play as investors respond to China's Big Tech curbs
Amid the crackdown on China’s tech giants, some investors are sussing out less risky sectors, while heavyweights like BlackRock and Fidelity stay in for the long haul
Aimentia: Pioneering mental health AI SaaS seeks to improve diagnosis as demand surges
Barcelona-based Aimentia supports the oft-overlooked mental health segment through digitalization and analytics, going beyond therapy platforms
Zoundream: Deciphering and mining the data in baby cries
The world’s first algorithm to translate baby cries into actionable insights for parents and hospitals seeks to boost early detection of pathologies and developmental disorders
Nuuk, the cooler box poised to disrupt cold chain logistics
Barcelona-based startup Groenlandia Tech has developed a smart cooler box to track and monitor biological samples, providing an extra layer of security and control during transport
Vence: Virtual fencing for sustainable livestock rearing
The startup uses GPS and AI algorithms to create virtual fences that work with animal collars for more efficient management of livestock and grasslands
TreeFrog Therapeutics: Mimicking how stem cells grow in the human body
The French biotech’s proprietory technology to cultivate pluripotent stem cells in a 3D environment can be scaled to mass-produce high-quality cells to treat diseases such as Parkinson’s
Therapixel: Using AI to improve breast cancer detection
Therapixel is raising €15m for commercial expansion of its AI-powered MammoScreen that gives accurate breast cancer screening results within minutes
HumanITcare: Covid-19 spurs demand for telemedicine across Spain and beyond
The startup’s revenue is expected to exceed €10m by 2024 due to rapid digital transformation of healthcare services and a growing market for AI-powered medtechs
POPULAR DATABASE
